CompletedPhase 3NCT00112554
Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia
Studying Acute basophilic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vion Pharmaceuticals
- Principal Investigator
- Bonny L. Johnson, RN, MSNVion Pharmaceuticals
- Intervention
- cytarabine(drug)
- Enrollment
- 420 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2008
Study locations (30)
- USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States
- University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- American Health Network - North Meridian, Indianapolis, Indiana, United States
- Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Nevada Cancer Institute, Las Vegas, Nevada, United States
- New Mexico Cancer Care Alliance, Albuquerque, New Mexico, United States
- Roswell Park Cancer Institute, Buffalo, New York, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00112554 on ClinicalTrials.govOther trials for Acute basophilic leukemia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT00898456Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaAlliance for Clinical Trials in Oncology